Characterizing Musculoskeletal Sequelae in Ebola Virus Survivors During the 7 Years Since Hospital Discharge in Eastern Sierra Leone - Scorecard - MDSpire

Characterizing Musculoskeletal Sequelae in Ebola Virus Survivors During the 7 Years Since Hospital Discharge in Eastern Sierra Leone

  • By

  • Anna C Sanford

  • Nell G Bond

  • Emily J Engel

  • Foday Alhasan

  • Michael Gbakie

  • Fatima Kamara

  • Lansana Kanneh

  • Ibrahim Mustapha

  • Mohamed Yillah

  • Donald Grant

  • Robert Samuels

  • John S Schieffelin

  • March 8, 2025

  • 0 min

Share

Clinical Scorecard: Evaluating Musculoskeletal Complications in Ebola Virus Survivors Seven Years Post-Hospital Discharge in Eastern Sierra Leone

At a Glance

CategoryDetail
ConditionPost-Ebola syndrome with musculoskeletal sequelae
Key MechanismsPost-viral musculoskeletal inflammation and joint involvement following Ebola virus disease
Target PopulationEbola virus disease survivors, particularly aged 15–40 years
Care SettingLongitudinal outpatient follow-up in post-Ebola treatment units and community settings

Key Highlights

  • Musculoskeletal sequelae including joint pain and tenderness are common in Ebola survivors up to 7 years post-discharge.
  • Survivors aged 15–40 years demonstrate the highest rates of musculoskeletal signs and symptoms.
  • Musculoskeletal sequelae generally decrease over time but show fluctuations during follow-up.

Guideline-Based Recommendations

Diagnosis

  • Assess for current joint or muscle pain and perform physical examination for joint tenderness, decreased range of motion, and joint edema/effusion.
  • Include abdominal tenderness assessment due to its association with musculoskeletal phenotype in post-Ebola syndrome.

Management

  • Recognize the need for targeted treatment for survivors presenting with musculoskeletal sequelae.
  • Consider longitudinal monitoring to track symptom progression and fluctuations.

Monitoring & Follow-up

  • Follow survivors longitudinally for up to 7 years post-discharge to evaluate persistence or resolution of musculoskeletal symptoms.
  • Monitor especially survivors aged 15–40 years who have higher odds of musculoskeletal complications.

Risks

  • Higher risk of musculoskeletal sequelae in survivors with shorter time from discharge and those reporting pre-Ebola musculoskeletal issues or depression.
  • No significant occupational risk factors identified after controlling for age, sex, and time from discharge.

Patient & Prescribing Data

Ebola virus disease survivors with post-Ebola musculoskeletal sequelae

Survivors with musculoskeletal symptoms may require specific and possibly prolonged treatment approaches; however, targeted therapies are not yet established.

Clinical Best Practices

  • Perform comprehensive musculoskeletal and abdominal examinations during survivor follow-up visits.
  • Use longitudinal data to inform individualized management plans for post-Ebola musculoskeletal sequelae.
  • Pay particular attention to survivors aged 15–40 years due to their higher prevalence of symptoms.
  • Incorporate mental health screening as depression is associated with reported musculoskeletal symptoms.

References

Original Source(s)

Related Content